Hamdan Medical Journal (previously the Journal of Medical Sciences)
|Table of Contents|
Assessment and Management of Hypertension in Children and Adolescents: Part B – Investigations and Management
McCrindle BW. Assessment and management of hypertension in children and adolescents. Nat Rev Cardiol 2010; 7: 155-63.
Fossali E, Intermite R, Minoja M, Tirelli S, Sereni F. The captopril test in children with renovascular and renal hypertension. Acta Paediatr 1996; 85: 1129-31.
Bravo EL, Tarazi RC, Gifford RW, Stewart BH. Circulating and urinary catecholamines in pheochromocytoma.Diagnostic and pathophysiologic implications. N Engl J Med 1979; 301: 682-6.
Abdulsamea S, Anderson P, Biassoni L, Brennan E, McLaren CA, Marks SD, et al. Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children. Pediatr Nephrol 2010; 25: 317-22.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-76.
Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol 2005; 20: 961-6.
Sinaiko AR. Treatment of hypertension in children. Pediatr Nephrol 1994; 8: 603-9.
Flynn JT, Daniels SR. Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 2006; 149: 746-54.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JAMA 2003; 289: 2560-72.
Sinaiko AR. Hypertension in children. N Engl J Med 1996; 335: 1968-73.
Rocchini AP, Katch V, Anderson J, Hinderliter J, Becque D, Martin M, et al. Blood pressure in obese adolescents: effect of weight loss. Pediatrics 1988; 82: 16-23.
Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996; 98: 649-58.
Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47: 296-308.
Aeberli I, Spinas GA, Lehmann R, l'Allemand D, Molinari L, Zimmermann MB. Diet determines features of the metabolic syndrome in 6- to 14-year-old children. Int J Vitam Nutr Res 2009; 79: 14-23.
Gonzalez-Juanatey JR, Paz FL, Eiras S, Teijeira- Fernandez E. [Adipokines as novel cardiovascular disease markers. Pathological and clinical considerations]. Rev Esp Cardiol 2009; 62 Suppl 2: 9-16.
Bhave S, Bavdekar A, Otiv M. IAP National Task Force for Childhood Prevention of Adult Diseases: Childhood Obesity. Indian Pediatr 2004; 41: 559-75.
Gutin B, Basch C, Shea S, Contento I, DeLozier M, Rips J, et al. Blood pressure, fitness, and fatness in 5- and 6- year-old children. JAMA 1990; 264: 1123-7.
Shea S, Basch CE, Gutin B, Stein AD, Contento IR, Irigoyen M, et al. The rate of increase in blood pressure in children 5 years of age is related to changes in aerobic fitness and body mass index. Pediatrics 1994; 94: 465-70.
Hofman A, Walter HJ, Connelly PA, Vaughan RD. Blood pressure and physical fitness in children. Hypertension 1987; 9: 188-91.
Council on Sports Medicine and Fitness and Council on School Health. Active healthy living: prevention of childhood obesity through increased physical activity. Pediatrics 2006; 117: 1834-42.
Fixler DE, Laird WP, Browne R, Fitzgerald V, Wilson S, Vance R. Response of hypertensive adolescents to dynamic and isometric exercise stress. Pediatrics 1979; 64: 579-83.
McCaffrey FM, Braden DS, Strong WB. Sudden cardiac death in young athletes. A review. Am J Dis Child 1991; 145: 177-83.
Kaplan NM, Opie LH. Controversies in hypertension. Lancet 2006; 367: 168-76.
Rames LK, Clarke WR, Connor WE, Reiter MA, Lauer RM. Normal blood pressure and the evaluation of sustained blood pressure elevation in childhood: the Muscatine study. Pediatrics 1978; 61: 245-51.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in highrisk hypertensive patients randomized to angiotensinconverting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.
Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003; 111: 1416-21.
Fivush B, Neu A, Furth S. Acute hypertensive crises in children: emergencies and urgencies. Curr Opin Pediatr 1997; 9: 233-6.
Fenves AZ, Ram CV. Drug treatment of hypertensive urgencies and emergencies. Semin Nephrol 2005; 25: 272- 80.
Yiu V, Orrbine E, Rosychuk RJ, MacLaine P, Goodyer P, Girardin C, et al. The safety and use of short-acting nifedipine in hospitalized hypertensive children. Pediatr Nephrol 2004; 19: 644-50.
Calvetta A, Martino S, von Vigier RO, Schmidtko J, Fossali E, Bianchetti MG. "What goes up must immediately come down!" Which indication for short-acting nifedipine in children with arterial hypertension? Pediatr Nephrol 2003; 18: 1-2.